New ASC drug CPT codes C9456, C9457 and Q9979

Drugs and Biologicals with Outpatient Prospective Payment System (OPPS) Pass-Through Status Effective October 1, 2015


o For October 2015, two new HCPCS codes have been created and are shown in Table 1 below for reporting drugs and biologicals in the ASC setting with OPPS pass-through status, where there have not previously been specific codes available.


HCPCS Code Short Descriptor Long Descriptor ASC PI

C9456 Inj, isavuconazonium sulfate Injection, isavuconazonium sulfate, 1 mg K2
C9457 Lumason contrast agent Injection, sulfur hexafluoride lipid microsphere, per ml K2



• New HCPCS Codes and Dosage Descriptors for Certain Drugs, Biologicals, and Biosimilar Biological Products


o Effective October 1, 2015, one new HCPCS code has been created for reporting drugs and biologicals in the ASC setting, where there have not previously been specific codes available. This new code is listed in Table 2 below.

HCPCS Code Short Descriptor Long Descriptor ASC PI

Q9979 Injection, alemtuzumab Injection, alemtuzumab, 1 mg K2